Related Experiment Video

Updated: May 24, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Controlling the outcome of the Toll-like receptor signaling pathways

Guilhem Richard1, Calin Belta, A Agung Julius

  • 1Program in Bioinformatics, Boston University, Boston, Massachusetts, United States of America.

Plos One
|February 25, 2012
PubMed

Insights

Targeting Toll-Like Receptors (TLRs) pathways, not just TLRs themselves, can control immune responses. Minimal Cut Sets analysis identified essential gene sets for disrupting these pathways, offering new therapeutic strategies.

Area of Science:

  • Immunology
  • Systems Biology
  • Computational Biology

Background:

  • Toll-Like Receptors (TLRs) are crucial immune proteins that regulate cytokine production.
  • Elevated cytokine levels can be detrimental, necessitating strategies to control TLR pathway activity.
  • While deleting TLRs can reduce cytokine levels, targeting other pathway components remains less understood.

Purpose of the Study:

  • To identify critical targets within Toll-Like Receptor (TLR) pathways for controlling immune responses.
  • To apply Minimal Cut Sets (MCS) analysis to a TLR pathway model (ihsTLR v1.0) for identifying reaction knockouts.
  • To determine Essential Gene Sets (EGS) for suppressing TLR network outputs.

Main Methods:

  • Utilized the Minimal Cut Sets (MCS) concept on the ihsTLR v1.0 model.
  • Decomposed the TLR network into 34 functional modules.
  • Mapped TLR network species to human and mouse genes to identify Essential Gene Sets (EGS).

Main Results:

  • Identified 2,669 MCS organized into 68 distinct signatures.
  • Discovered that very few MCS directly targeted TLRs, suggesting limited efficacy of direct TLR targeting.
  • Uncovered over 10,000 Essential Gene Sets (EGS) in human and mouse, representing potential targets for pathway disruption.

Conclusions:

  • Direct targeting of Toll-Like Receptors (TLRs) may not be the most effective strategy for controlling immune responses.
  • Minimal Cut Sets (MCS) analysis reveals alternative targets within TLR pathways.
  • Essential Gene Sets (EGS) offer a comprehensive resource for developing novel therapeutic interventions against TLR-mediated inflammation.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...